Business Description
Edesa Biotech Inc
NAICS : 325412
SIC : 3741
ISIN : CA85855A3029
Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 48.28 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -59 | |||||
| 3-Year EPS without NRI Growth Rate | -58.1 | |||||
| 3-Year FCF Growth Rate | -58.5 | |||||
| 3-Year Book Growth Rate | -22 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.26 | |||||
| 9-Day RSI | 58.46 | |||||
| 14-Day RSI | 55.5 | |||||
| 6-1 Month Momentum % | 10.55 | |||||
| 12-1 Month Momentum % | -26.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.97 | |||||
| Quick Ratio | 1.97 | |||||
| Cash Ratio | 1.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.8 | |||||
| Shareholder Yield % | -12.95 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -106.32 | |||||
| ROA % | -83.67 | |||||
| ROIC % | -300.21 | |||||
| ROC (Joel Greenblatt) % | -7417 | |||||
| ROCE % | -109.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.44 | |||||
| Price-to-Tangible-Book | 6.82 | |||||
| EV-to-EBIT | -1.6 | |||||
| EV-to-EBITDA | -1.65 | |||||
| EV-to-Forward-EBITDA | -1.54 | |||||
| EV-to-Forward-Revenue | 5.15 | |||||
| EV-to-FCF | -1.9 | |||||
| Price-to-Net-Current-Asset-Value | 7.14 | |||||
| Price-to-Net-Cash | 23.2 | |||||
| Earnings Yield (Greenblatt) % | -62.5 | |||||
| FCF Yield % | -42.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EDSA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Edesa Biotech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.379 | ||
| Beta | 0.34 | ||
| Volatility % | 58.13 | ||
| 14-Day RSI | 55.5 | ||
| 14-Day ATR ($) | 0.306511 | ||
| 20-Day SMA ($) | 4.50048 | ||
| 12-1 Month Momentum % | -26.83 | ||
| 52-Week Range ($) | 2.4603 - 8.3331 | ||
| Shares Outstanding (Mil) | 3.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Edesa Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Edesa Biotech Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Edesa Biotech Inc Frequently Asked Questions
What is Edesa Biotech Inc(EDSA)'s stock price today?
The current price of EDSA is $4.64. The 52 week high of EDSA is $8.33 and 52 week low is $2.46.
When is next earnings date of Edesa Biotech Inc(EDSA)?
The next earnings date of Edesa Biotech Inc(EDSA) is 2024-08-09 Est..
Does Edesa Biotech Inc(EDSA) pay dividends? If so, how much?
Edesa Biotech Inc(EDSA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers